Ira A. Weiss

Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL.

ViroXis Corp. develops and commercializes bio-pharmaceuticals derived from sandalwood oils for viral diseases. The company was founded in 2006 by Ian William David Clements and Paul Castella and is headquartered in San Antonio, TX.

BiO2 Medical, Inc. engages in the design, development, and manufacturing of clinical products. The company was founded by Luis F. Angel, Christopher E. Banas, and Paul Castella in December 2006 and is headquartered in Golden, CO.

Incyte Venture Partners LLC (Incyte Venture Partners) is a venture capital firm founded in 2009. The firm is headquartered in San Antonio, Texas.

CytoBioscience, Inc. manufactures medical devices. It creates and manufactures devices that represent a convergence of bioscience, nano science, microchip development, algorithms and engineering. The firm offers CRO services. The company is headquartered in San Antonio, TX.

Greer Capital Advisors LLC (GCA) is a private equity/venture capital firm founded in 2002 by Lawrence W. Greer. The firm is headquartered in Mountain Brook, Alabama.

Innovative Trauma Care, Inc. develops and markets medical devices for traumatic injuries. It is an early stage medical device company focused on developing and marketing solutions to address the common causes of preventable death in traumatic injury scenarios. The firm's product iTClamp Hemorrhage Control System is a temporary wound closure device to control severe bleeding within seconds of application to a penetrating injury. Its product iTClamp seals the edges of a wound closed to create a temporary pool of blood under pressure, which forms a stable clot that mitigates further blood loss until the wound can be surgically repaired. The company was founded by Ian Joseph Atkinson and Dennis Frank Filips in 2010 and is headquartered in San Antonio, TX.

StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX.

DiscoveryBioMed, Inc. provides human cell-based drug discovery services. It provides pilot screening and high-throughput screening services for therapeutic-related bioassays, custom immortalized cell lines and therapeutics discovery for certain failure-to-secrete diseases in humans. The company was founded by Erik M. Schwiebert in October 2007 and is headquartered in Birmingham, AL.

Part of DURECT Corp., Southern BioSystems, Inc. is a company that manufactures and develops biodegradable polymer and non-polymer drug delivery systems. The company is based in Birmingham, AL. The company was founded by Alan H. Dean. Southern BioSystems was acquired by DURECT Corp. on April 30, 2001 for $13.64 million.

Southern Research Institute is a scientific research organization. It focuses on research in drug discovery, drug development, energy and environment, and engineering. The firm serves pharmaceutical, biotechnology, defense, aerospace, environmental, and energy industries The company was founded in 1941 and is headquartered in Birmingham, AL.

Vivo Biosciences, Inc. develops platform for preclinical research, drug discovery and therapeutics. Its products include ready to use HuBiogel, angio-start assay kit, custom products, and mini-tumor assay plates. It also offers pre-clinical drug testing services, efficient 3D bioassay platform, and other HuBiogel applications. The company was founded by Lawrence J. DeLucas and Raj K. Singh in 2004 and is headquartered in Birmingham, AL.

Hera Biotech, Inc. is a women's health company based in San Antonio, TX. Hera Biotech is focused on transforming women's health with its revolutionary non-surgical test for early diagnosis and staging of endometriosis, called MetriDx™. The company was founded in 2020 by Paul Castella, Bruce Nicholson, Nameer Kirma, and Somer Baburek, who has been the CEO since incorporation.